Jangwoen Lee1, Sari B Mahon2, David Mukai2, Tanya Burney2, Behdod S Katebian3, Adriano Chan3, Vikhyat S Bebarta4, David Yoon2, Gerry R Boss3, Matthew Brenner2,5. 1. Beckman Laser Institute, University of California, 1002 Health Sciences Rd., Irvine, CA, 92612-1475, USA. jangwl@uci.edu. 2. Beckman Laser Institute, University of California, 1002 Health Sciences Rd., Irvine, CA, 92612-1475, USA. 3. Department of Medicine, University of California, San Diego, La Jolla, CA, 92093-0652, USA. 4. Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, 80045, USA. 5. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, Irvine, CA, 92868, USA.
Abstract
INTRODUCTION: Cyanide is a major chemical threat, and cyanide ingestion carries a higher risk for a supra-lethal dose exposure compared to inhalation but provides an opportunity for effective treatment due to a longer treatment window and a gastrointestinal cyanide reservoir that could be neutralized prior to systemic absorption. We hypothesized that orally administered cobinamide may function as a high-binding affinity scavenger and that gastric alkalinization would reduce cyanide absorption and concurrently increase cobinamide binding, further enhancing antidote effectiveness. METHODS: Thirty New Zealand white rabbits were divided into five groups and were given a lethal dose of oral cyanide poisoning (50 mg). The survival time of animals was monitored with oral cyanide alone, oral cyanide with gastric alkalinization with oral sodium bicarbonate buffer (500 mg), and in combination with either aquohydroxocobinamide or dinitrocobinamide (250 mM). Red blood cell cyanide concentration, plasma cobinamide, and thiocyanate concentrations were measured from blood samples. RESULTS: In cyanide ingested animals, oral sodium bicarbonate alone significantly prolonged survival time to 20.3 ± 8.6 min compared to 10.5 ± 4.3 min in saline-treated controls, but did not lead to overall survival. Aquohydroxocobinamide and dinitrocobinamide increased survival time to 64 ± 41 (p < 0.05) and 75 ± 16.4 min (p < 0.001), respectively. Compared to aquohydroxocobinamide, dinitrocobinamide showed greater systemic absorption and reduced blood pressure. Dinitrocobinamide also markedly increased the red blood cell cyanide concentration. Under all conditions, the plasma thiocyanate concentration gradually increased with time. CONCLUSION: This study demonstrates a promising new approach to treat high-dose cyanide ingestion, with gastric alkalinization alone and in combination with oral cobinamide for treating a supra-lethal dose of orally administered cyanide in rabbits.
INTRODUCTION:Cyanide is a major chemical threat, and cyanide ingestion carries a higher risk for a supra-lethal dose exposure compared to inhalation but provides an opportunity for effective treatment due to a longer treatment window and a gastrointestinal cyanide reservoir that could be neutralized prior to systemic absorption. We hypothesized that orally administered cobinamide may function as a high-binding affinity scavenger and that gastric alkalinization would reduce cyanide absorption and concurrently increase cobinamide binding, further enhancing antidote effectiveness. METHODS: Thirty New Zealand white rabbits were divided into five groups and were given a lethal dose of oral cyanidepoisoning (50 mg). The survival time of animals was monitored with oral cyanide alone, oral cyanide with gastric alkalinization with oral sodium bicarbonate buffer (500 mg), and in combination with either aquohydroxocobinamide or dinitrocobinamide (250 mM). Red blood cell cyanide concentration, plasma cobinamide, and thiocyanate concentrations were measured from blood samples. RESULTS: In cyanide ingested animals, oral sodium bicarbonate alone significantly prolonged survival time to 20.3 ± 8.6 min compared to 10.5 ± 4.3 min in saline-treated controls, but did not lead to overall survival. Aquohydroxocobinamide and dinitrocobinamide increased survival time to 64 ± 41 (p < 0.05) and 75 ± 16.4 min (p < 0.001), respectively. Compared to aquohydroxocobinamide, dinitrocobinamide showed greater systemic absorption and reduced blood pressure. Dinitrocobinamide also markedly increased the red blood cell cyanide concentration. Under all conditions, the plasma thiocyanate concentration gradually increased with time. CONCLUSION: This study demonstrates a promising new approach to treat high-dose cyanide ingestion, with gastric alkalinization alone and in combination with oral cobinamide for treating a supra-lethal dose of orally administered cyanide in rabbits.
Authors: Kate E Broderick; Prasanth Potluri; Shunhui Zhuang; Immo E Scheffler; Vijay S Sharma; Renate B Pilz; Gerry R Boss Journal: Exp Biol Med (Maywood) Date: 2006-05
Authors: S Merritt; G Gulsen; G Chiou; Y Chu; C Deng; A E Cerussi; A J Durkin; B J Tromberg; O Nalcioglu Journal: Technol Cancer Res Treat Date: 2003-12
Authors: Jae G Kim; Jangwoen Lee; Sari B Mahon; David Mukai; Steven E Patterson; Gerry R Boss; Bruce J Tromberg; Matthew Brenner Journal: J Biomed Opt Date: 2012-10 Impact factor: 3.170
Authors: Matthew Brenner; Sari B Mahon; Jangwoen Lee; Jae Kim; David Mukai; Seth Goodman; Kelly A Kreuter; Rebecca Ahdout; Othman Mohammad; Vijay S Sharma; William Blackledge; Gerry R Boss Journal: J Biomed Opt Date: 2010 Jan-Feb Impact factor: 3.170
Authors: Matthew Brenner; Jae G Kim; Jangwoen Lee; Sari B Mahon; Daniel Lemor; Rebecca Ahdout; Gerry R Boss; William Blackledge; Lauren Jann; Herbert T Nagasawa; Steven E Patterson Journal: Toxicol Appl Pharmacol Date: 2010-08-10 Impact factor: 4.219
Authors: Adriano Chan; Jingjing Jiang; Alla Fridman; Ling T Guo; G Diane Shelton; Ming-Tao Liu; Carol Green; Kristofer J Haushalter; Hemal H Patel; Jangwoen Lee; David Yoon; Tanya Burney; David Mukai; Sari B Mahon; Matthew Brenner; Renate B Pilz; Gerry R Boss Journal: J Med Chem Date: 2015-02-16 Impact factor: 7.446
Authors: Bryant M Moeller; Daune L Crankshaw; Jacquie Briggs; Herbert T Nagasawa; Steven E Patterson Journal: Toxicol Lett Date: 2017-04-12 Impact factor: 4.372
Authors: Patrick C Ng; Tara B Hendry-Hofer; Alyssa E Witeof; Matthew Brenner; Sari B Mahon; Gerry R Boss; Philippe Haouzi; Vikhyat S Bebarta Journal: J Med Toxicol Date: 2019-05-06
Authors: Patrick C Ng; Tara B Hendry-Hofer; Alyssa E Witeof; Matthew Brenner; Sari B Mahon; Gerry R Boss; Vikhyat S Bebarta Journal: Comp Med Date: 2018-09-12 Impact factor: 0.982
Authors: Tara B Hendry-Hofer; Patrick C Ng; Alison M McGrath; Kirsten Soules; David S Mukai; Adriano Chan; Joseph K Maddry; Carl W White; Jangwoen Lee; Sari B Mahon; Matthew Brenner; Gerry R Boss; Vikhyat S Bebarta Journal: Inhal Toxicol Date: 2020-12-26 Impact factor: 2.724
Authors: Patrick C Ng; Tara B Hendry-Hofer; Matthew Brenner; Sari B Mahon; Gerry R Boss; Joseph K Maddry; Vikhyat S Bebarta Journal: J Med Toxicol Date: 2021-04-05
Authors: Matthew Brenner; Sarah M Azer; Kyung-Jin Oh; Chang Hoon Han; Jangwoen Lee; Sari B Mahon; Xiaohua Du; David Mukai; Tanya Burney; Mayer Saidian; Adriano Chan; Derek I Straker; Vikhyat S Bebarta; Gerry R Boss Journal: J Clin Toxicol Date: 2017-06-27